Skip to main content

Ejaculatory Dysfunction

  • Chapter
  • First Online:
Sexual Medicine

Abstract

While erectile dysfunction has received much-needed publicity, ejaculatory disorders are far more common and affect over 30% of men in the age group of 40–80 years [1–3]. Ejaculatory dysfunction encompasses a spectrum of conditions, namely, premature ejaculation (PE), delayed ejaculation (DE) and anejaculation (AE) that includes retrograde ejaculation (RE). Due to the lack of standardized definitions for these problems, the clinical diagnosis and management strategies for ejaculatory dysfunctions are somewhat arbitrary. Ejaculatory dysfunction not only affects a man’s sexual health but can also interfere with his fertility when conception is desired, thereby resulting in significant distress for both partners [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Laumann E, Nicolosi A, Glasser D, Paik A, Gingell C, Moreira E, Wang T. Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the global study of sexual attitudes and behaviors. Int J Impot Res. 2005;17:39–57.

    Article  CAS  Google Scholar 

  2. Nicolosi A, Laumann EO, Glasser DB, Moreira ED Jr, Paik A, Gingell C. Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology. 2004;64:991–7.

    Article  Google Scholar 

  3. Montorsi F. Prevalence of premature ejaculation: a global and regional perspective. J Sex Med. 2005;2(suppl 2):96–102.

    Article  Google Scholar 

  4. Khan SD, Pandiyan N. Ejaculatory dysfunction—a mini review. Adv Sex Med. 2015;5:39–42.

    Article  CAS  Google Scholar 

  5. Masters WH, Johnson VE. Reproductive biology research foundation (US). Human sexual response. 1st ed. Boston: Little, Brown; 1966.

    Google Scholar 

  6. Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. J Sex Med. 2005;2:492–7.

    Article  Google Scholar 

  7. Waldinger M, Zwinderman A, Olivier B, Schweitzer D. Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data. J Sex Med. 2005;2:498–507.

    Article  Google Scholar 

  8. Donatucci CF. Etiology of ejaculation and pathophysiology of premature ejaculation. J Sex Med. 2006;3(4 suppl):303–8.

    Article  CAS  Google Scholar 

  9. Kimura Y, Kisaki N, Sakurada S, Tadano T. On the brain monoaminergic systems relating to ejaculation. II. Brain serotonin and ejaculation. Andrologia. 1977;9:50–4.

    Article  CAS  Google Scholar 

  10. Hull EM, Du J, Lorrain DS, Matuszewich L. Extracellular dopamine in the medial preoptic area: implications for sexual motivation and hormonal control of copulation. J Neurosci. 1995;15:7465–71.

    Article  CAS  Google Scholar 

  11. Peroutka SJ, Snyder SH. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol. 1979;16:687–99.

    CAS  PubMed  Google Scholar 

  12. Ahlenius SLK, Svensson L, Hjorth S, Carlsson A, Lindberg P, Wikström H, Sanchez D, Arvidsson LE, Hacksell U, Nilsson JL. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav. 1981;15:785–92.

    Article  CAS  Google Scholar 

  13. Meisel RL, Sachs BD. The physiology of male sexual behavior. In: Knobil E, Neill JD, editors. The physiology of reproduction. 3rd ed. New York: Raven Press; 2005. p. 3–105.

    Google Scholar 

  14. Olivier B, van Oorschot R, Waldinger MD. Serotonin, serotenergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Int Clin Psychopharmacol. 1998;13(suppl 6):S9–S14.

    Article  Google Scholar 

  15. Mos J, Mollet I, Tolbloom JT, et al. A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat. Eur Neuropsychopharmacol. 1999;9:123–35.

    Article  CAS  Google Scholar 

  16. Argiolas A, Melis MR. The role of oxytocin and the paraventricular nucleus in the sexual behaviour of male mammals. Physiol Behav. 2004;83:309–17.

    Article  CAS  Google Scholar 

  17. Andersson KE. Pharmacology of penile erection. Pharmacol Rev. 2001;53:417–50.

    CAS  PubMed  Google Scholar 

  18. Patrick DL, Althof SE, Pryor JL, Rosen R, Rowland DL, Ho KF, et al. Premature ejaculation: an observational study of men and their partners. J Sex Med. 2005;2:58–367.

    Article  Google Scholar 

  19. McMahon CG, Althof SE, Waldinger MD, et al. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med. 2008;5:1590–606.

    Article  Google Scholar 

  20. Schapiro B. Premature ejaculation, a review of 1130 cases. J Urol. 1943;50:374–9.

    Article  Google Scholar 

  21. Waldinger MD. Premature ejaculation: definition and drug treatment. Drugs. 2007;67:547–68.

    Article  CAS  Google Scholar 

  22. Janssen PKC, Bakker SC, Rethelyi J, Zwinderman AH, Touw DJ, Olivier B, et al. Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation. J Sex Med. 2009;6:276–84. Early-on-line.

    Article  CAS  Google Scholar 

  23. Corona G, Petrone L, Mannucci E, Jannini EA, Mansani R, Magini A, et al. Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions. Eur Urol. 2004;46:615–22.

    Article  CAS  Google Scholar 

  24. Sharlip ID. Guidelines for the diagnosis and management of premature ejaculation. J Sex Med. 2006;3(4 suppl):309–17.

    Article  CAS  Google Scholar 

  25. Atkinson RL, Dahms WT, Fisher DA, Nichols AL. Occult thyroid disease in an elderly hospitalized population. J Gerontol. 1978;33:372–6.

    Article  CAS  Google Scholar 

  26. Althof SE, Abdo CH, Dean J, Hackett G, McCabe M, McMahon CG, Rosen RC, Sadovsky R, Waldinger M, Becher E, Broderick GA, Buvat J, Goldstein I, El-Meliegy AI, Giuliano F, Hellstrom WJ, Incrocci L, Jannini EA, Park K, Parish S, Porst H, Rowland D, Segraves R, Sharlip I, Simonelli C, Tan HM. International Society for Sexual Medicine. International Society for Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med. 2010;7:2947–69.

    Article  Google Scholar 

  27. McMahon CG. The etiology and management of premature ejaculation. Nat Clin Pract Urol. 2005;2:426–33.

    Article  Google Scholar 

  28. Jannini EA, Lenzi A, Wagner G. Behavioural therapy and counselling. In: Schill WB, Comhaire FH, Hargreave TB, editors. Andrology for the clinician. Berlin: Springer; 2006. p. 598–607.

    Chapter  Google Scholar 

  29. McCarthy B. Cognitive-behavioral strategies and techniques in the treatment of early ejaculation. In: Leiblum SR, Rosen RC, editors. Principles and practice of sex therapy: update for the 90s. New York: Guilford Press; 1990. p. 141–67.

    Google Scholar 

  30. Metz M, McCarthy B. Coping with premature ejaculation: how to overcome PE, please your partner and have great sex. Oakland, CA: New Harbinber Publications; 2003.

    Google Scholar 

  31. Zilbergeld B. The new male sexuality. New York: Bantam; 1992.

    Google Scholar 

  32. Lowe JC, Mikulas WL. Use of written material in learning self-control of premature ejaculation. Psychol Rep. 1975;37:295–8.

    Article  CAS  Google Scholar 

  33. Berkovitch M, Keresteci AG, Koren G. Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. J Urol. 1995;154:1360–1.

    Article  CAS  Google Scholar 

  34. Xin ZC, Choi YD, Lee SH, Choi HK. Efficacy of a topical agent SS-cream in the treatment of premature ejaculation: preliminary clinical studies. Yonsei Med J. 1997;38:91–5.

    Article  CAS  Google Scholar 

  35. Busato W, Galindo CC. Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo controlled study. BJU Int. 2004;93:1018–21.

    Article  CAS  Google Scholar 

  36. Choi H, Xin ZC, Cho IR. The local therapeutic effect of SS-cream on premature ejaculation. Korean J Androl Soc. 1993;11:99–106.

    Google Scholar 

  37. Atikeler MK, Gecit I, Senol FA. Optimum usage of prilocaine-lidocaine cream in premature ejaculation. Andrologia. 2002;34:356–9.

    Article  CAS  Google Scholar 

  38. Dinsmore WW, Hackett G, Goldmeier D, et al. Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation. BJU Int. 2007;99(2):369–75.

    Article  CAS  Google Scholar 

  39. Hellstrom WJ, Althof S, Gittelman M, et al. Dapoxetine for the treatment of men with premature ejaculation (PE): dose finding analysis. J Urol. 2005;173:238; abstract 877

    Article  Google Scholar 

  40. Buvat J, Tesfaye F, Rothman M, Rivas DA, Giuliano F. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol. 2009;55:957–67.

    Article  CAS  Google Scholar 

  41. Pryor JL, Althof SE, Steidle C, et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet. 2006;368:929–37.

    Article  CAS  Google Scholar 

  42. McMahon C, Kim S, Park N, et al. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase iii double-blind, parallel-group study of dapoxetine. J Sex Med. 2010;7:256–68.

    Article  CAS  Google Scholar 

  43. Waldinger M. Towards evidenced based drug treatment research on premature ejaculation: a critical evaluation of methodology. J Impot Res. 2003;15:309–13.

    Article  CAS  Google Scholar 

  44. Haensel SM, Klem TM, Hop WC, Slob AK. Fluoxetine and premature ejaculation a double-blind, crossover, placebocontrolled study. J Clin Psychopharmacol. 1998;18:72–7.

    Article  CAS  Google Scholar 

  45. Biri H, Isen K, Sinik Z, Onaran M, Kupeli B, Bozkirli I. Sertraline in the treatment of premature ejaculation: a double-blind placebo controlled study. Int Urol Nephrol. 1998;30:611–5.

    Article  CAS  Google Scholar 

  46. Jannini E, Lenzi A. Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping. World J Urol. 2005;23:68–75.

    Article  Google Scholar 

  47. Jern P, Santtila P, Witting K, Alanko K, Harlaar N, Johansson A, Sandnabba K. Premature and delayed ejaculation: genetic and environmental effects in a population based sample of Finnish twins. J Sex Med. 2007;4:1739–49.

    Article  Google Scholar 

  48. McMahon C, Abdo C, Incrocci L, Perelman M, Rowland D, Waldinger M, Xin Z. Disorders of orgasm and ejaculation in men. J Sex Med. 2004;1:58–65.

    Article  Google Scholar 

  49. Harley LM, Chen Y, Rattner WH. Prune belly syndrome. J Urol. 1972;108:174–6.

    Article  CAS  Google Scholar 

  50. Zugor V, Schott G, Labanaris A. The prune belly syndrome: urological aspects and long-term outcomes of a rare disease. Pediatr Rep. 2012;4:e20.

    Article  Google Scholar 

  51. Rowland D, McMahon C, Abdo C, Chen J, Jannini E, Waldinger M, Ahn T. Disorders of orgasm and ejaculation in men. J Sex Med. 2010;7(Pt 2):1668–86.

    Article  Google Scholar 

  52. Perelman MA, Rowland DL. Retarded ejaculation. World J Urol. 2006;24:645–52.

    Article  Google Scholar 

  53. Pettus J, Carver B, Masterson T, Stasi J, Sheinfeld J. Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer. Urology. 2009;73:328.

    Article  Google Scholar 

  54. Coogan C, Hejase M, Wahle G, Foster R, Rowland R, Bihrle R, Donohue J. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer. J Urol. 1996;156:1656–8.

    Article  CAS  Google Scholar 

  55. Romero F, Romero K, Mattos M, Garcia C, Fernandes R, Perez M. Sexual function after partial penectomy for penile cancer. Urology. 2005;66:1292–5.

    Article  Google Scholar 

  56. Rosen R, Altwein J, Boyle P, Kirby R, Lukacs B, Meuleman E, Giuliano F. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44:637–49.

    Article  Google Scholar 

  57. Carani C, Isidori A, Granata A, Carosa E, Maggi M, Lenzi A, Jannini E. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab. 2005;90:6472–9.

    Article  CAS  Google Scholar 

  58. Corona G, Mannucci E, Petrone L, Fisher A, Balercia G, De Scisciolo G, Maggi M. Psychobiological correlates of delayed ejaculation in male patients with sexual dysfunctions. J Androl. 2006;27:453–8.

    Article  Google Scholar 

  59. Bors E, Comarr AE. Neurological disturbances of sexual function with special reference to 529 patients with spinal cord injury. Urol Surv. 1960;10:191–221.

    Google Scholar 

  60. Comarr AE. Sexual function among patients with spinal cord injury. Urol Int. 1970;25:134–68.

    Article  CAS  Google Scholar 

  61. Hendry WF, Altof SE, Benson GS, et al. Male orgasmic and ejaculatory disorders. In: Jardin A, Wagner G, Khoury S, Giuliano F, Padma-Hathan H, Rosen R, editors. Erectile dysfunction. Paris: Health Publication, Ltd. Distributed by Plymbridge, Plymouth; 2000. p. 477–506.

    Google Scholar 

  62. Schlegel PN, Shin D, Goldstein M. Urogenital anomalies in men with congenital absence of the vas deferens. J Urol. 1996;155:1644–8.

    Article  CAS  Google Scholar 

  63. Mickle J, Milunsky A, Amos JA, Oates RD. Congenital unilateral absence of the vas deferens: a heterogeneous disorder with two distinct subpopulations based upon aetiology and mutational status of the cystic fibrosis gene. Hum Reprod. 1995;10:1728–35.

    Article  CAS  Google Scholar 

  64. McCarthy B. Strategies and techniques for the treatment of ejaculatory inhibition. J Sex Ed Ther. 1981;7:20–3.

    Article  Google Scholar 

  65. Pandiyan N, Khan SD. A clinical approach to male infertility. In: Gunasekaran K, Pandiyan N, editors. Male infertility. New Delhi: Springer; 2017.

    Google Scholar 

  66. McMahon CG, Waldinger M, Rowland DL, et al. Ejaculatory disorders. In: Porst H, Buvat J, editors. Standard practice in sexual medicine. Oxford: Blackwell Publishing; 2006. p. 188–209.

    Chapter  Google Scholar 

  67. Kaplan H. The evaluation of sexual disorders: psychological and medical aspects. New York: Brunner/Mazel; 1995.

    Google Scholar 

  68. Barbach LG. For yourself: a guide to female orgasmic response. New York: Doubleday; 1974.

    Google Scholar 

  69. Heiman JR, Meston CM. Empirically validated treatment for sexual dysfunction. Annu Rev Sex Res. 1997;8:148–94.

    CAS  PubMed  Google Scholar 

  70. McCormick S, Olin J, Brotman AW. Reversal of fluoxetine induced anorgasmia by cyproheptadine in two patients. J Clin Psychiatry. 1990;51:383–4.

    CAS  PubMed  Google Scholar 

  71. Ashton K, Hamer R, Rosen R. Serotonin reuptake inhibitor induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther. 1997;23:165–75.

    Article  Google Scholar 

  72. Feder R. Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients. J Clin Psychiatry. 1991;52:163–4.

    CAS  PubMed  Google Scholar 

  73. Lauerma H. Successful treatment of citalopram-induced anorgasmia by cyproheptadine. Acta Psychiatr Scand. 1996;93:69–70.

    Article  CAS  Google Scholar 

  74. Kamischke A, Nieschlag E. Treatment of retrograde ejaculation and anejaculation. Hum Reprod Update. 1999;5(5):448–74.

    Article  CAS  Google Scholar 

  75. Safarinejad MR. Midodrine for the treatment of organic anejaculation but not spinal cord injury: a prospective randomized placebo-controlled double-blind clinical study. Int J Impot Res. 2009;21(4):213–20.

    Article  CAS  Google Scholar 

  76. Pandiyan N, Pandiyan R, Muthiah S, Moorthy PS, Kanakaraj S. Sperm retrieval from the bladder-A simple non-invasive technique. Fertil Steril. 1998;70:1187.

    Article  Google Scholar 

  77. Brackett NL, Ibrahim E, Iremashvili V, Aballa TC, Lynne CM. Treatment for ejaculatory dysfunction in men with spinal cord injury: an 18-year single center experience. J Urol. 2010;183(6):2304–8.

    Article  Google Scholar 

  78. Arafa MM, Zohdy WA, Shamloul R. Prostatic massage: a simple method of semen retrieval in men with spinal cord injury. Int J Androl. 2007;30(3):170–3.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Natarajan, P., Khan, S.D. (2019). Ejaculatory Dysfunction. In: Gunasekaran, K., Khan, S. (eds) Sexual Medicine . Springer, Singapore. https://doi.org/10.1007/978-981-13-1226-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-1226-7_4

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-1225-0

  • Online ISBN: 978-981-13-1226-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics